首页 | 本学科首页   官方微博 | 高级检索  
     


The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate‐resistant prostate cancer
Authors:Rahul Aggarwal MD  Susan Halabi PhD  William Kevin Kelly DO  Daniel George MD  John F. Mahoney MD  Frederick Millard MD  Walter M. Stadler MD  Michael J. Morris MD  Philip Kantoff MD  J. Paul Monk MD  Michael Carducci MD  Eric J. Small MD  for the Alliance for Clinical Trials in Oncology
Affiliation:1. Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, , San Francisco, California;2. Department of Biostatistics and Bioinformatics and Alliance Statistics and Data Center, Duke University Medical Center, , Durham, North Carolina;3. Department of Medical Oncology, Thomas Jefferson University, , Philadelphia, Pennsylvania;4. Department of Medicine‐Oncology, Duke University Medical Center, , Durham, North Carolina;5. Carolinas Medical Center, , Charlotte, North Carolina;6. Division of Hematology‐Oncology, University of California San Diego, , San Diego, California;7. Section of Hematology, Oncology, University of Chicago, , Chicago, Illinois;8. Department of Medicine, Genitourinary Oncology Service, Memorial Sloan‐Kettering Cancer Center, , New York, New York;9. Department of Medicine, Dana‐Farber Cancer Institute, , Boston, Massachusetts;10. Department of Internal Medicine, The Ohio State University, , Columbus, Ohio;11. Department of Oncology and Urology, The Johns Hopkins University, , Baltimore, Maryland;12. Department of Medicine and Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, , San Francisco, California
Abstract:
Keywords:prostatic neoplasms  chemotherapy  ketoconazole  steroid 17‐alpha‐hydroxylase  androgen antagonists
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号